Poster abstracts

The submission deadline to submit abstracts for the 29th ADLM International CPOCT Symposium has passed. Authors of accepted abstracts will be invited to display their poster(s) during the conference and must register to do so.

Key details and dates

• Authors will need to present their posters at the conference in person to be included in the abstract publication.
• Presented poster abstracts will be published as a supplement issue in ADLM's online peer-reviewed publication, The Journal of Applied Laboratory Medicine (JALM).
• 29th ADLM International CPOCT Symposium will be held September 25 - 27, 2024.
• If you plan to withdraw your abstract, please notify education@myadlm.org in writing as soon as possible including the abstract title and author name.

Poster preparation guidelines & requirements

Poster size and display board

ADLM does not provide poster printing services. It is the responsibility of poster presenters to prepare and print their poster(s) for display on the provided poster boards. Please review the size and space information carefully as you prepare your poster.

• The maximum size for an accepted poster is 46 inches (117 cm) x 46 inches (117 cm). If your poster exceeds the limit, it may be cut, folded, or otherwise modified to permit the allotted display room.
• The poster abstract number provided by ADLM will be placed in the upper corner and measures 8.5 inches wide by 5.5 inches high (approximately 22 cm x 14 cm).

Required poster information

Each accepted poster must contain the following information:

• Title as submitted in your abstract submission.
• Presenting author and all co-authors.
• Author(s) affiliation(s).
• Background of your study (why you did this work).
• Method(s) used to achieve a solution.
• Results obtained (figures, tables, etc.).
• Conclusions and importance of your work to laboratory medicine.
  Please note that ADLM only provides the poster abstract number placed in the upper corner. It is the responsibility of the poster presenter to print and display their poster(s) at the designated times.

General poster guidance

• The information you display should have a professional appearance.
• All information should be easily read from at least 5 feet away from your poster.
• Headings for abstract title and numbering for subsections should be a minimum of 72 pt font (approximately 1 inch or 2.5 cm height).
• Subheadings should be a minimum of 36 pt font (approximately 0.5 inches or 1 cm height).
• All type should be a minimum of 24 pt font (approximately 0.3 inches or 0.8 cm height) and readable from a distance of 5-7 feet (1.5-1.7 meters).

Restrictions

• Instruments, components, or reagents are NOT permitted in the poster area.

Poster session schedule

You are required to set up your poster between 3 – 5 pm on Wednesday, September 25, 2024. Please collect your badge at the registration table and identify your poster number for your spot in the poster presentation section.

Your poster is to remain on display for the entire duration of the conference and removed by Friday, September 27, 2024 by 4:00 pm.

ADLM is not responsible for posters left on boards after the conference concludes.

List of accepted scientific poster abstracts

Accepted posters are listed in alphabetical order, by last name. Poster numbers will be assigned before the conference. Poster presentations will be on display starting Wednesday , September 25 at 5:00 pm. Poster displays conclude at the end of the conference on Friday, September 27 at 4:00 pm.

1. Kingston 3-year Study of Thrice Daily Testing of Blood Samples on Dual Blood Gas/Electrolyte Analyzers Demonstrates 16-24 Hour New Cartridge Instability
   George Cembrowski, Alberta Precision Laboratories, Edmonton, AB, Canada
2. Making Sense of College of American Pathologists External Quality Assessments of the GEM 5000
   George Cembrowski, University of Alberta, Edmonton, AB, Canada
3. Mathematical Design Specifications and Strategic Point-of-care Requirements for COVID-19 Tests, New Infectious Diseases Threats, and 21st Century Pandemics
   Gerald Kost, University of California, Davis, Davis, CA, United States
4. Bridging the Gap: A Point-of-care Testing Telehealth Training Program for Enhanced Patient Care
   Gerald Kost, University of California, Davis, Davis, CA, United States
5. Assessing the Impact of Micro Clot Errors on GEM Premier 5000 Analyzer Results in a Point of Care Setting
   Sally Ezra, Alberta Precision Laboratories and University of Calgary, Calgary, AB, Canada
6. Concurrent Spurious Hypoxemia and Undetectable Blood Glucose on the Blood Gas Analyser: Pseudo or Real? (WITHDRAWN)
   Prabin Gyawali, NSW Health Pathology, Sydney, NSW, Australia
7. Mobile HbA1c Testing: Can a Point-of-Care Analyzer Still Work After Ground Transportation?
   Sahir Eusuff, UC Davis School of Medicine, Sacramento, CA, United States
8. Clinical Performance of a Novel Point-of-Care Coagulometer for the DOACs
   Sasha Bakhru, Perosphere Technologies Inc., Danbury, CT, United States
9. Evaluation of the Roche Cobas Pulse Point of Care Glucose Meter
   Isla Craig, Eastern Ontario Regional Laboratories Association, Ottawa, ON, Canada
10. Evaluation of Pro-QCP, a Process Approach for Clinical Labs to Develop Risk-Based Quality Control Plans
    William Donohue, CarePoint Solutions Inc., Beverly, MA, United States
11. Clinical Concordance between Viscoelastic Testing Methods for Transfusion Indication
    Nicholas Larkey, University of Virginia, Charlottesville, VA, United States
12. Evaluation of Hemolysis Rates in Adult and Pediatric Whole Blood Specimens at the Point of Care
    Robert Maynard, University of Kentucky Medical Center, Lexington, KY, United States
13. Assessment of In Vitro Hemolysis Using Three Commercially Available Methods
    Nicholas McNary, Werfen, Bedford, MA, United States
14. Accuracy and Precision Evaluation a Novel Point-of-Care Coagulometer for the DOACs
    Dardan Osmani, Perosphere Technologies Inc., Danbury, CT, United States
15. Hemolysis Detection and Flagging of Potassium Results on GEM Premier 7000 with iQM3
    Prasad Pamidi, Werfen, Bedford, MA, United States
16. Novel In-line Hemolysis Detection on a Blood Gas Analyzer for Capillary Samples
    Prasad Pamidi, Werfen, Bedford, MA, United States
17. Critical Limits and Critical Values for Urgent Clinician Notification at Major US Medical Centers
    Jenna Dohner, UC Davis, San Diego, CA, United States
18. Detection of Human Immunodeficiency Virus (HIV) Proteins in Extracellular Vesicles (EVs) by Immunocapture Lateral Flow Method
    Kimberly Luke, Intuitive Biosciences, Madison, WI, United States
19. Validation of Capillary Blood Gas Specimen Delivery by a Pneumatic Tube System
    Kuldeep Dhillon, University of California San Francisco Medical Center, San Francisco, CA, United States
20. Validation of The Quantra® Hemostasis System with the QPlus® Cartridge at an Academic Hospital
    Pedro Castaneda, M Health Fairview University of Minnesota Medical Center, Minneapolis, MN, United States
21. Delivering Better and Timely Diagnosis for Critical Patients: POC Clinical Performance versus Central Laboratory Assays in Key Cardiac Markers
    Jorge Aldunate, Redsalud, Santiago, Chile
22. Clinical and Analytical Performance Evaluation of Savanna RVP4 Panel versus Three Methodologies
    Jorge Aldunate, Redsalud, Santiago, Chile
23. Improving Diagnostic Support for Preeclampsia Diagnosis: Clinical Evaluation of Triage PLGF Assay in Gynecology Department at Clinica Redsalud Santiago
    Jorge Aldunate, Redsalud, Santiago, Chile
24. Evaluation of the Impact of Heat exposure on i-STAT CHEM8+ Cartridges and a Repurposed i-STAT Transport Case for Use in Mobile Health Settings
    Anna Fuezery, Alberta Precision Laboratories, Edmonton, AB, Canada
25. Comparison of Whole Blood And Plasma Measurements Using Roche B221, Abbott Istat And Beckman Au5800
    Robert Hawkins, Tan Tock Seng Hospital, Singapore, Singapore
26. POCT Whole Blood Creatinine Testing For Assessing Radiology Intravenous Contrast Risk
    Robert Hawkins, Tan Tock Seng Hospital, Singapore, Singapore
27. Validation of the Haemonetics® TEG® 6s Analyzer and the Benefit of Point of Care Testing Expert Participation
    Heather Paul, Alberta Precision Laboratories, Calgary, AB, Canada
28. Observational Assessment of the Trends in Glycemic Control Observed through the Utilization of Donated Point of Care HbA1c Testing at Free and Charitable Clinic
    Heidi Schutz, Heart to Heart International, Lenexa, KS, United States
29. Visualizing Critical Limits and Critical Values Facilitates Understanding of Life-Threatening Test Results, Medical Decision Thresholds, and Pathophysiological Interpretation
    Ania Shah, University of California, Davis, Davis, CA, United States
30. From Lab to Bedside: Comparative Evaluation of Blood Gas Testing With i-STAT Alinity System
    Rebecca Tan, Singapore General Hospital, Singapore, Singapore
31. Benchmarking the miniDxR: Enhancing Lateral Flow Assay Performance for Point-of-Care Diagnostics
    Patrick Vaughan, DCN Dx, Carlsbad, California, United States
32. Electronic Documentation of Point of Care Testing Waived and Non-Waived Training and Competency Assessment Forms using Microsoft SharePoint Software and Applications
    Monica Nicolas, Children's Hospital Los Angeles, Los Angeles, CA, United States
33. Evaluation of Novel Colloids to Enhance Assay Sensitivity in POC Testing
    Kevin Jones, XHG Labs, Cleveland, OH, United States
    
    

Questions?

Email education@myadlm.org.